From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection

類似資料

• Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infection
  著者:: Kudalkar, Shalley N., 等
  出版事項: (2018)
• Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection
  著者:: Kudalkar, Shalley N., 等
  出版事項: (2017)
• Correction for Kudalkar et al., From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection
  出版事項: (2018)
• Structural and Pharmacological Evaluation of a Novel Non-nucleoside Reverse Transcriptase Inhibitor as a Promising Long Acting Nanoformulation for Treating HIV
  著者:: Kudalkar, Shalley N., 等
  出版事項: (2019)
• Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography
  著者:: Chan, Albert H., 等
  出版事項: (2017)